Reuters: Health
Indian pharmaceutical company Strides Pharma Science Ltd said on Thursday it has obtained regulatory approval to conduct clinical trials of antiviral drug favipiravir, a potential treatment for COVID-19.
Strides Pharma to conduct trials in India for potential COVID-19 drug
Strides Pharma to conduct trials in India for potential COVID-19 drug
Reuters: Health
Indian pharmaceutical company Strides Pharma Science Ltd said on Thursday it has obtained regulatory approval to conduct clinical trials of antiviral drug favipiravir, a potential treatment for COVID-19.
Reuters: Health
Indian pharmaceutical company Strides Pharma Science Ltd said on Thursday it has obtained regulatory approval to conduct clinical trials of antiviral drug favipiravir, a potential treatment for COVID-19.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment